AZN Stock Earnings: AstraZeneca Misses EPS, Beats Revenue for Q2 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
AZN stock results show that AstraZeneca missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
The post AZN Stock Earnings: AstraZeneca Misses EPS, Beats Revenue for Q2 2024 appeared first on InvestorPlace.
More From InvestorPlace